Clinical trial
The Dose Effects of Isomaltulose and Sucrose on Glycaemic and Insulinemic Response
NCT04653207 is registered in ClinicalTrials.gov with Singapore Institute of Food and Biotechnology Innovation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Dose Effects of Isomaltulose and Sucrose on Glycaemic and Insulinemic Response
- Lead sponsor
- Singapore Institute of Food and Biotechnology Innovation
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- March 1, 2018
- Completion date
- October 28, 2020
- Enrollment
- 64 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
obesity, pre diabetes, type 2 diabetes